1st Quarter - Report

ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$1,330,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report (this page) Apr 20, 2011 $1,330,000 Replaced
1st Quarter - Amendment Aug 10, 2011 $1,350,000 Yes

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Issues related to reform of tax code and possible timing of any such reform (no bill number yet)

LobbyistCovered position, as disclosed
DANNY LY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); State, Dept of (DOS); Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA)

Copyright/Patent/Trademark CPT

HR 6331 - patent issues associated with anti-biotics S. 3677, HR 4899 - legislative proposals surrounding patent reform and intellectual property issues, including patent settlements Participate in executive branch discussions regarding intellectual property issues arising in foreign countries

LobbyistCovered position, as disclosed
ANDREW KAPLAN —
DANNY LY —
BRADLEY ALLEN ROSSIN —

Contacted: State, Dept of (DOS); SENATE; Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA)

Bills named: S. 3677 (112th), H.R. 4899 (112th), H.R. 6331 (112th)

Health Issues HCR

HR 3590, S. 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to health care reform legislation and implementation, including the newly-created Independent Payment Advisory Board Monitoring and discussing issues under discussion by the President's Deficit Commission, including recommendations regarding the Independent Payment Advisory Board and Medicare Part D rebates (unassigned) HR 6331 - issues related to legislation regarding development of antibiotics HR 3590, S. 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to health care reform legislation and implementation, including transparency ("Sunshine") reporting requirements 340B Drug Pricing program issues, including expansion of eligible entities and impacts of health care reform changes

LobbyistCovered position, as disclosed
CHRISTINE BLOOMQUIST —
RICHARD BUCKLEY —
ANDREW KAPLAN —
DANNY LY —
BRADLEY ALLEN ROSSIN —
HEATHER STRAWN New Leg. Dir. Rep. Mike Rogers (MI) 1/01 - 3/05

Contacted: HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); Commerce, Dept of (DOC); SENATE; State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Bills named: H.R. 6331 (112th), S. 1790 (112th), H.R. 3590 (112th), H.R. 4872 (112th)

Medicare/Medicaid MMM

HR 3590, S. 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to Medicare Part D Coverage Gap Program HR 3590, S. 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to Medicaid price reporting, rebate calculation, and expansion of eligible utilization Issues related to identification and correction of medical edit codes

LobbyistCovered position, as disclosed
CHRISTINE BLOOMQUIST —
ANDREW KAPLAN —
DANNY LY —
RICHARD WAYNE OLSON —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; State, Dept of (DOS); Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC)

Bills named: S. 1790 (112th), H.R. 4872 (112th), H.R. 3590 (112th)

Consumer Issues/Safety/Products CSP

S. 525 and related legislative proposals regarding prescription drug importation and safety issues

LobbyistCovered position, as disclosed
BRADLEY ALLEN ROSSIN —
HEATHER STRAWN New Leg. Dir. Rep. Mike Rogers (MI) 1/01 - 3/05

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); SENATE; Health Resources & Services Administration (HRSA)

Bills named: S. 525 (112th)

Pharmacy PHA

FDA funding issues, including issues such as user fees and possible future appropriations that are likely to be incorporated into the Prescription Drug User Fee Act (PDUFA) V (no bill number yet)

LobbyistCovered position, as disclosed
ANDREW KAPLAN —
DANNY LY —
BRADLEY ALLEN ROSSIN —
HEATHER STRAWN New Leg. Dir. Rep. Mike Rogers (MI) 1/01 - 3/05

Contacted: State, Dept of (DOS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); SENATE; Commerce, Dept of (DOC)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.